A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 26694930)

Published in PLoS One on December 22, 2015

Authors

Katherine James1,2, Shereen Al-Ali2,3, Jessica Tarn2, Simon J Cockell4, Colin S Gillespie5, Victoria Hindmarsh6, James Locke2, Sheryl Mitchell6, Dennis Lendrem2, Simon Bowman7, Elizabeth Price8, Colin T Pease9, Paul Emery9, Peter Lanyon10, John A Hunter11, Monica Gupta11, Michele Bombardieri12, Nurhan Sutcliffe12, Costantino Pitzalis12, John McLaren13, Annie Cooper14,15, Marian Regan16, Ian Giles17, David Isenberg17, Vadivelu Saravanan18, David Coady19, Bhaskar Dasgupta20, Neil McHugh21, Steven Young-Min15, Robert Moots22, Nagui Gendi23, Mohammed Akil24, Bridget Griffiths6, UK Primary Sjögren’s Syndrome registry, Anil Wipat1, Julia Newton6,25, David E Jones2, John Isaacs2,26, Jennifer Hallinan1,27, Wan-Fai Ng2,26

Author Affiliations

1: Interdisciplinary Computing and Complex BioSystems Research Group, Newcastle University, Newcastle upon Tyne, United Kingdom.
2: Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
3: Department of Biology, College of Science, University of Basrah, Basrah, Iraq.
4: Bioinformatics Support Unit, Newcastle University, Newcastle upon Tyne, United Kingdom.
5: School of Mathematics & Statistics, Newcastle University, Newcastle upon Tyne, United Kingdom.
6: Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
7: Rheumatology Department, University Hospital Birmingham, Birmingham, United Kingdom.
8: Great Western Hospitals NHS Foundation Trust, Swindon, United Kingdom.
9: Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds & NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals Trust, Leeds, United Kingdom.
10: Nottingham University Hospital, Nottingham, United Kingdom.
11: Gartnavel General Hospital, Glasgow, United Kingdom.
12: Barts and the London NHS Trust & Barts and the London School of Medicine and Dentistry, London, United Kingdom.
13: NHS Fife, Whyteman's Brae Hospital, Kirkcaldy, United Kingdom.
14: Royal Hampshire County Hospital, Winchester, United Kingdom.
15: Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom.
16: Royal Derby Hospital, Derby, United Kingdom.
17: University College London Hospitals NHS Foundation Trust, London, United Kingdom.
18: Queen Elizabeth Hospital, Gateshead, United Kingdom.
19: Sunderland Royal Hospital, Sunderland, United Kingdom.
20: Southend University Hospital, Southend, United Kingdom.
21: Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom.
22: Aintree University Hospitals, Liverpool, United Kingdom.
23: Basildon Hospital, Basildon, United Kingdom.
24: Royal Hallamshire Hospital, Sheffield, United Kingdom.
25: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
26: National Institute for Health Research, Newcastle Biomedical Research Centre, Newcastle upon Tyne, United Kingdom.
27: BioThink Pty Ltd, Brisbane, Australia.

Articles cited by this

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46

Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19

The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 121.58

KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00

Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91

The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology (1982) 79.76

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet (2003) 53.59

Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics (2006) 22.61

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis (2002) 20.48

lumi: a pipeline for processing Illumina microarray. Bioinformatics (2008) 17.19

Reactome: a knowledge base of biologic pathways and processes. Genome Biol (2007) 13.36

Molecular signatures database (MSigDB) 3.0. Bioinformatics (2011) 8.08

Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature (2002) 6.26

arrayQualityMetrics--a bioconductor package for quality assessment of microarray data. Bioinformatics (2008) 5.95

Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res (2003) 4.93

American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) (2012) 4.82

Sjögren's syndrome. Lancet (2005) 4.81

The human Arp2/3 complex is composed of evolutionarily conserved subunits and is localized to cellular regions of dynamic actin filament assembly. J Cell Biol (1997) 4.34

Validity and reliability of a scale to assess fatigue. Psychiatry Res (1991) 3.87

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc Natl Acad Sci U S A (2006) 3.11

Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum (2004) 3.06

Fatigue in multiple sclerosis. Arch Neurol (1988) 2.77

Tired, weak, or in need of rest: fatigue among general practice attenders. BMJ (1990) 2.70

Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci U S A (2003) 2.48

Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science (1993) 2.40

Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum (2005) 2.21

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis (2009) 2.20

Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann Clin Biochem (1993) 2.12

Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer (1996) 2.01

Fatigue in patients with cancer. Eur J Cancer (1998) 1.99

Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol (1990) 1.94

Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N Engl J Med (2014) 1.89

Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain Behav Immun (2008) 1.78

Cellular signaling in macrophage migration and chemotaxis. J Leukoc Biol (2000) 1.69

Peripheral blood gene expression profiling in Sjögren's syndrome. Genes Immun (2009) 1.66

United Kingdom Primary Sjogren's Syndrome Registry--a united effort to tackle an orphan rheumatic disease. Rheumatology (Oxford) (2010) 1.61

Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis (2008) 1.59

The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs (1994) 1.55

Immunological aspects of chronic fatigue syndrome. Autoimmun Rev (2008) 1.42

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis (2011) 1.37

Fatigue in primary biliary cirrhosis. Gut (1998) 1.32

Wiskott Aldrich syndrome protein (WASP) and N-WASP are critical for T cell development. Proc Natl Acad Sci U S A (2007) 1.31

Cancer-related fatigue--mechanisms, risk factors, and treatments. Nat Rev Clin Oncol (2014) 1.29

Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis. Ann Rheum Dis (2014) 1.28

Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer (1999) 1.28

Fatigue and chronic fatigue syndrome-like complaints in the general population. Eur J Public Health (2009) 1.24

Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome. J Intern Med (2011) 1.21

Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Gut (2002) 1.21

Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. PLoS One (2010) 1.17

Systemic increase in type I interferon activity in Sjögren's syndrome: a putative role for plasmacytoid dendritic cells. Eur J Immunol (2008) 1.17

Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis (2012) 1.16

Interferon-mediated fatigue. Cancer (2001) 1.14

A study of fatigue in systemic lupus erythematosus. J Rheumatol (1990) 1.13

Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndrome. Arthritis Rheum (2008) 1.08

Fatigue in primary Sjögren's syndrome. Ann Rheum Dis (1998) 1.08

Fractionation of the beta subunit common to guanine nucleotide-binding regulatory proteins with the cytoskeleton. Mol Pharmacol (1986) 1.06

20 years of leptin: role of leptin in energy homeostasis in humans. J Endocrinol (2014) 1.05

Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool. Rheumatology (Oxford) (2004) 1.05

Primary Sjogren's syndrome: too dry and too tired. Rheumatology (Oxford) (2010) 1.00

Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum (2007) 0.98

Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. J Clin Pathol (2009) 0.97

Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology. J Transl Med (2013) 0.96

Predictors of subjective fatigue among individuals with rheumatoid arthritis. Arthritis Rheum (1998) 0.96

Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenomics J (2009) 0.94

Gene expression in peripheral blood leukocytes in monozygotic twins discordant for chronic fatigue: no evidence of a biomarker. PLoS One (2009) 0.92

Tubulin, actin and heterotrimeric G proteins: coordination of signaling and structure. Biochim Biophys Acta (2013) 0.92

A gene signature for post-infectious chronic fatigue syndrome. BMC Med Genomics (2009) 0.90

Interaction of G protein Gbetagamma dimers with small GTP-binding proteins of the Rho family. FEBS Lett (1996) 0.88

Are vasoactive neuropeptide autoimmune fatigue-related disorders mediated via G protein-coupled receptors? Med Hypotheses (2005) 0.85

Fatigue in multiple sclerosis. Curr Neurol Neurosci Rep (2001) 0.84

Physical capacity in women with primary Sjögren's syndrome: a controlled study. Arthritis Rheum (2003) 0.84

Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome. Neuropsychobiology (2011) 0.83

Assessment of a 44 gene classifier for the evaluation of chronic fatigue syndrome from peripheral blood mononuclear cell gene expression. PLoS One (2011) 0.83

The regulating function of heterotrimeric G proteins in the immune system. Arch Immunol Ther Exp (Warsz) (2013) 0.83

Low DPP4 expression and activity in multiple sclerosis. Clin Immunol (2013) 0.81

Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome. Psychoneuroendocrinology (2013) 0.80

New agents for the treatment of cancer-related fatigue. Cancer (2001) 0.79

Rhinorrhea, cough and fatigue in patients taking sitagliptin. Allergy Asthma Clin Immunol (2010) 0.78

Meta analysis of Chronic Fatigue Syndrome through integration of clinical, gene expression, SNP and proteomic data. Bioinformation (2011) 0.76